Adjustments for Non-Cash Items (USD, millions)

Stock-Based Compensation (USD, millions)

Changes in Working Capital (USD, millions)

Capital Expenditures (CapEx) (USD, millions)

Proceeds from / Repayments of Debt (USD, millions)

Share Repurchases (USD, millions)

Dividend Payments (USD, millions)

Net Change in Cash (USD, millions)

2f06ad4dd94bac3b235dcebf67f8b6d367cf6e72ce0bf18f070561c86d9420af

Total Revenue (USD, millions)

Cost of Goods Sold (COGS) (USD, millions)

SG&A (USD, millions)

R&D (USD, millions)

D&A (USD, millions)

Interest Expense (USD, millions)

Operating Income (EBIT) (USD, millions)

Net Income (USD, millions)

EPS - Basic (USD)

EPS - Diluted (USD)

b3b6c56c72846fb9bb66050bd889fedc8b679dc055a9f8a621c0c83a154b54d2

Current Assets (USD, millions)

Cash and Cash Equivalents (USD, millions)

Accounts Receivable (USD, millions)

Inventory (USD, millions)

Non-Current Assets (USD, millions)

Property, Plant, and Equipment (PP&E) (USD, millions)

Goodwill (USD, millions)

Intangible Assets (USD, millions)

Current Liabilities (USD, millions)

Accounts Payable (USD, millions)

Short-term Debt (USD, millions)

Accrued Expenses (USD, millions)

Non-Current Liabilities (USD, millions)

Long-term Debt (USD, millions)

Lease Liabilities (USD, millions)

Deferred Tax Liabilities (USD, millions)

Shareholders' Equity (USD, millions)

Retained Earnings (USD, millions)

Common Stock (USD, millions)

Additional Paid-in Capital (USD, millions)

0933876bd1161208ddd3fd3686bc9aa4beb36cc1ca14d1dddd1bc685f94909d6

Net income (loss) [USD, millions]

Depreciation and amortization [USD, millions]

Stock-based compensation expense [USD, millions]

Goodwill and intangibles impairment [USD, millions]

Loss on RH disposal [USD, millions]

Net losses on asset dispositions and asset impairments [USD, millions]

Changes in operating assets and liabilities, net of acquisition (Total) [USD, millions]

Changes in Accounts receivable [USD, millions]

Changes in Inventories [USD, millions]

Changes in Prepaid expenses and other assets [USD, millions]

Changes in Accounts payable [USD, millions]

Changes in Accrued expenses [USD, millions]

Changes in Deferred income taxes and other [USD, millions]

Deferred income taxes and other [USD, millions]

Cash Provided by (Used in) Operating Activities [USD, millions]

Capital expenditures [USD, millions]

Proceeds from RH Divestiture post-closing settlement [USD, millions]

Proceeds from the RH divestiture [USD, millions]

Acquisition of assets and businesses, net of cash acquired [USD, millions]

Investments in non-affiliates / Note Receivable [USD, millions]

Cash Used in Investing Activities [USD, millions]

Proceeds from issuance of secured debt [USD, millions]

Secured debt repayments [USD, millions]

Debt issuance costs [USD, millions]

Revolving credit facility proceeds [USD, millions]

Revolving credit facility repayments [USD, millions]

Purchases of treasury stock [USD, millions]

Proceeds from the exercise of stock options [USD, millions]

Payment of contingent consideration liabilities [USD, millions]

Cash (Used in) Provided by Financing Activities [USD, millions]

Effect of Exchange Rate Changes on Cash and Cash Equivalents [USD, millions]

Increase (Decrease) in Cash and Cash Equivalents [USD, millions]

Cash paid (refunded) for income taxes [USD, millions]

Cash paid for interest [USD, millions]

Capital expenditures included in accounts payable or accrued expenses [USD, millions]

Cash and Cash Equivalents - Beginning of Period/Year [USD, millions]

Cash and Cash Equivalents - End of Period/Year [USD, millions]

aeae2cc5a089557a0fc7b839922256f7f76311dac45bb4f6f4cbeec0c0f086df

Net Sales (USD, millions)

Cost of products sold (USD, millions)

Gross Profit (USD, millions)

Research and development expenses (USD, millions)

Selling and general expenses (USD, millions)

Goodwill and intangibles impairment (USD, millions)

Other (income) expense, net (USD, millions)

Operating Income (Loss) (USD, millions)

Interest income (USD, millions)

Interest expense (USD, millions)

Income (Loss) Before Income Taxes (USD, millions)

Income tax provision (benefit) (USD, millions)

Income (Loss) from Continuing Operations (USD, millions)

(Loss) Income from discontinued operations, net of tax (USD, millions)

Net Income (Loss) (USD, millions)

Basic Earnings (Loss) Per Share - Continuing operations (USD)

Basic Earnings (Loss) Per Share - Discontinued operations (USD)

Basic Earnings (Loss) Per Share (USD)

Diluted Earnings (Loss) Per Share - Continuing operations (USD)

Diluted Earnings (Loss) Per Share - Discontinued operations (USD)

Diluted Earnings (Loss) Per Share (USD)

Common Shares Outstanding - Basic (millions)

Common Shares Outstanding - Diluted (millions)

66ba0a17bd43860d43fb41adfe003fd371c0cdb463f0142bb6a2d54ffd2b1179

Cash and cash equivalents (USD, millions)

Accounts receivable, net (USD, millions)

Inventories (USD, millions)

Prepaid and other current assets (USD, millions)

Assets held for sale (USD, millions)

Total Current Assets (USD, millions)

Property, Plant and Equipment, net (USD, millions)

Operating Lease Right-of-Use Assets (USD, millions)

Other Intangible Assets, net (USD, millions)

Deferred Tax Assets (USD, millions)

Other Assets (USD, millions)

TOTAL ASSETS (USD, millions)

Current portion of long-term debt (USD, millions)

Current portion of operating lease liabilities (USD, millions)

Trade accounts payable (USD, millions)

Accrued expenses (USD, millions)

Liabilities held for sale (USD, millions)

Total Current Liabilities (USD, millions)

Long-Term Debt (USD, millions)

Operating Lease Liabilities (USD, millions)

Other Long-Term Liabilities (USD, millions)

Total Liabilities (USD, millions)

Additional paid-in capital (USD, millions)

Accumulated deficit (USD, millions)

Treasury stock (USD, millions)

Accumulated other comprehensive loss (USD, millions)

Total Stockholders’ Equity (USD, millions)

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (USD, millions)

ca02b4a0758277bd1cfe28d80804af8def3fcf1a64d3a4404f18833d3ae8e1fb

Digestive Health

Pain Management and Recovery

- Surgical Pain and Recovery

- Interventional Pain

Total Revenue

ea90365b85747b453f64f95898acef9629eb508ca3ffc5e680822cd4c5565ef5

Cost related to EU MDR compliance (USD millions)

254bf8a983b6af1f303e1b841c2dc55eb66dbddd5ae2990f3126eb99166f5aa2

North America

Europe, Middle East, and Africa

Asia Pacific and Latin America

1cbf883ab5ca7b631152ff284286ed3bbce88a5883c1dcfb9d7df2839f4ca363

Avanos Medical Inc (AVNS)

Financials